Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 9Lung Neoplasms 6Carcinoma, Non-Small-Cell Lung 4Prostatic Neoplasms 3Barrett Esophagus 3Stomach Neoplasms 2Recurrence 2Rectal Neoplasms 2Pancreatic Neoplasms 2Neoplasms 2Multiple Pulmonary Nodules 2Melanoma 2Glioma 2Colorectal Neoplasms 2Adenocarcinoma of Lung 2Triple Negative Breast Neoplasms 1Thyroid Nodule 1Thyroid Neoplasms 1Spinal Fractures 1Solitary Pulmonary Nodule 1Smoking Cessation 1Small Cell Lung Carcinoma 1Skin Neoplasms 1Phyllodes Tumor 1Osteoporosis 1Nevus 1Neoplastic Cells, Circulating 1Neoplasm Metastasis 1Lymphoma, Follicular 1Lung Diseases 1

Interventions

Cisplatin 55Carboplatin 50pembrolizumab 42Paclitaxel 42Gemcitabine 28Pemetrexed 23Radiotherapy 21Magnetic Resonance Spectroscopy 20Radiotherapy, Intensity-Modulated 18Cetuximab 18Docetaxel 17Specimen Handling 16Nivolumab 16Fluorouracil 16Cyclophosphamide 14durvalumab 13Bevacizumab 13Sorafenib 12Radiation 11130-nm albumin-bound paclitaxel 11Sunitinib 10Platinum 101,2-diaminocyclohexaneplatinum II citrate 10osimertinib 9Oxaliplatin 8Irinotecan 8Ipilimumab 8Everolimus 8Drug Therapy 8Capecitabine 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma × Diagnostic Imaging × Clear all
NCT05035407 2025-12-02

T Cell Receptor Gene Therapy Targeting KK-LC-1 for Gastric, Breast, Cervical, Lung and Other KK-LC-1 Positive Epithelial Cancers

National Institutes of Health Clinical Center (CC)

Phase 1 Terminated
36 enrolled 7 charts
Breast

Carcinoma, Neoplasm Metastasis, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡